In our experiments, anti-PD-L1 treatment was associated with an increased survival of B16F10-mice during GCV-mediated tumor elimination, although BLI measurements revealed no difference in tumor burden of surviving anti-PD-L1-treated and control mice (Figures 1B, C). Here, CD274 is linked to neoplasm.